Skip to main content

Genetic

Genetic drive to overeat found in labradors and humans


Dogs that are constantly hungry and prone to being overweight share a common bit of biology with some obesity-prone humans. This is what UK scientists have discovered - identifying a genetic source of many labradors' - and some people's - tendency to overeat.

Researchers found that changes in a particular gene, one of the building blocks of biological code that produces the blueprint for how our bodies work, alters the chemical signals that tell our brains we've had enough to eat. The scientists say their findings, published in the journal Science, reveal something "powerful" about the biology of obesity risk.

"By studying dogs, we've honed in on some interesting new biology here," explained lead researcher Dr Eleanor Raffan from the University of Cambridge's department of physiology, development and neuroscience. She added that the discovery showed that "owners of slim dogs are not morally superior - and the same is true of slim people".

"If you have a high genetic risk of obesity, you're prone to gaining weight unless you put a huge effort into not doing so. And those with low genetic risk just don't have to work so hard."This canine-human biological link came from the researchers' examination of the genetics of 250 labradors. The team looked for pieces of genetic code that were common in overweight dogs.

They picked out one gene in particular - called DENND1B - that was associated with a higher body mass in the labradors. And when they searched through a library of genetic information from thousands of humans, they discovered that the same gene was associated with a higher body mass in people, too.

Before this study of labrador genetics, Dr Raffan said, "no one suspected that gene had anything to do with obesity". The gene interferes with a brain signalling pathway that helps regulate our appetite. Dr Raffan explained: "It alters the predisposition to weight gain because it's tweaking a system that is involved in regulating how hungry we feel and how much energy we burn off."

The findings could help in the future development of new drugs to tackle obesity. But the scientists say they reveal how much harder people - and owners of dogs - with this genetic predisposition have to work to offset its effects. Another member of the research team, Alyce McClellan, from Cambridge University added that the results emphasised "the importance of fundamental brain pathways in controlling appetite and body weight".

The discovery adds to a developing picture of those pathways and the biological driving forces behind overeating. A group of weight loss drugs, that includes Ozempic, target some of this biology, and have exploded in popularity in recent years. What we've identified here is a different pathway [from the one targeted by those drugs]," explained Dr Raffan. "But it all speaks to the same important bit of biology, which is that obesity is not about having low willpower.

"It's about the fact that some people are prone to weight gain because they have a genetic risk which increases their responsiveness to food and their appetite. "This goes for dogs and humans alike - they have a genetic drive to overeat." 

Genetic predisposition, obesity, Labrador retrievers, human genetics, POMC gene, appetite regulation, overeating behavior, metabolic disorders, energy balance, food motivation, satiety signals, inherited traits, canine obesity, weight management, evolutionary adaptation, pet health, dietary control, genetic mutation, body mass index, hunger hormones,

#GeneticDrive #Overeating #LabradorRetrievers #HumanGenetics #POMCGene #AppetiteRegulation #ObesityResearch #MetabolicDisorders #FoodMotivation #SatietySignals #InheritedTraits #CanineObesity #WeightManagement #EvolutionaryAdaptation #PetHealth #DietaryControl #GeneticMutation #BodyMassIndex #HungerHormones #HealthScience

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more